I. Khilfeh

发表

Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals

Shaloo Gupta, S. Garbarini, T. Nazareth, 2021, Dermatology and Therapy.

Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database

M. Broder, I. Khilfeh, K. Bognar, 2022, Open access rheumatology : research and reviews.

Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use.

I. Khilfeh, E. Chang, P. Desai, 2022, Journal of comparative effectiveness research.

The Humanistic and Economic Burden of Pediatric Focal Seizures in the United States

I. Yermilov, I. Khilfeh, Jiyoon C. Choi, 2020, Journal of child neurology.

Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics.

J. Curtis, I. Khilfeh, Jashin J. Wu, 2020, Journal of comparative effectiveness research.

Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis

I. Khilfeh, C. Udeze, D. Kaplan, 2020, ClinicoEconomics and outcomes research : CEOR.

CEOR_A_251775 369..377

I. Khilfeh, C. Udeze, D. Kaplan, 2020 .

Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy

T. Nazareth, I. Khilfeh, J. Hetherington, 2022, The Journal of dermatological treatment.

Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis

J. Curtis, I. Khilfeh, Jashin J. Wu, 2020, Advances in Therapy.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2022, Urologic oncology.

The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers

Shaun A. Hussain, C. Begley, Shaloo Gupta, 2020, Epilepsia.

Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamide.

I. Khilfeh, P. Lefebvre, D. Pilon, 2022, Future oncology.

Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis.

I. Khilfeh, C. Udeze, D. Kaplan, 2021, Journal of comparative effectiveness research.

Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study.

John B. Watkins, I. Khilfeh, D. Gross, 2019, Journal of managed care & specialty pharmacy.

Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.

E. Muser, I. Khilfeh, P. Lefebvre, 2023, Urologic oncology.

Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race

I. Khilfeh, M. Bilen, D. Pilon, 2024, ClinicoEconomics and outcomes research : CEOR.